Cargando…
Treatment Outcomes and Clinical Relevance in Patients with Double Expressor DLBCL
BACKGROUND: Double-expressor lymphoma (DEL) was found to account for 20–30% of DLBCL. We conducted this study to analyze the survival, the clinical presentation, and the factors associated with treatment outcomes in DEL-DLBCL. METHODS: A retrospective study of 291 patients diagnosed with DLBCL durin...
Autores principales: | Rungwittayatiwat, Sirapat, Boonsakan, Paisarn, Chantrathammachart, Pichika, Puavilai, Teeraya, Pukiat, Sulada, Phusanti, Sithakom, Boonyawat, Kochawan, Wacharapornin, Pathawut, Angchaisuksiri, Pantep, Ungkanont, Artit, Chuncharunee, Suporn, Niparuck, Pimjai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577552/ https://www.ncbi.nlm.nih.gov/pubmed/34804437 http://dx.doi.org/10.4084/MJHID.2021.063 |
Ejemplares similares
-
Treatment outcome and prognostic factors in PCNSL
por: Niparuck, Pimjai, et al.
Publicado: (2019) -
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
por: Niparuck, Pimjai, et al.
Publicado: (2019) -
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
por: Boonyawat, Kochawan, et al.
Publicado: (2020) -
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
por: Boonyawat, Kochawan, et al.
Publicado: (2020) -
Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais
por: Noikongdee, Phichchapha, et al.
Publicado: (2021)